These new conditions are alpha- and beta-thalassemia, carnitine acylcarnitine translocase deficiency (CACT), carnitine palmitoyltransferase deficiency type 1 (CPT1), carnitine palmitoyltransferase deficiency type 2 (CPT2), galactokinase deficiency (GALK), guanidinoacetate methyltransferase deficiency (GAMT), beta-ketothiolase deficiency (BKT), methylmalonic acidemia (MMA), mucopolysaccharidosis type 1 (MPS I), organic cation transporter 2 deficiency (OCTN 2), propionic acidemia (PA), X-linked adrenoleukodystrophy (X-ALD) and SCID [11]. Here, CPT2 is linked to X-linked adrenoleukodystrophy.